Dr. Kehl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3468
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
- Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
- Northwestern University The Feinberg School of MedicineClass of 2008
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MA State Medical License 2012 - 2026
- NH State Medical License 2024 - 2024
- TX State Medical License 2014 - 2019
- IL State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Collaborative large language models for automated data extraction in living systematic reviews.Muhammad Ali Khan, Umair Ayub, Syed Arsalan Ahmed Naqvi, Kaneez Zahra Rubab Khakwani, Zaryab Bin Riaz Sipra
Journal of the American Medical Informatics Association. 2025-01-21 - 2 citationsEnhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes ...Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, Vineet K Raghu, Chia-Yun Wu
Journal of Clinical Oncology. 2024-12-10 - 3 citationsAutomated real-world data integration improves cancer outcome prediction.Justin Jee, Christopher Fong, Karl Pichotta, Thinh Ngoc Tran, Anisha Luthra
Nature. 2024-12-01
Press Mentions
- Computer Platform Helps Match Patients with Cancer to Trials of Targeted TherapyOctober 12th, 2022
- Lack of Guideline-Concordant Treatment for Early-Stage Non-Small Cell Lung Cancer CommonMay 13th, 2022
- ‘More Effort Needed’ to Optimize Use of Standard Early NSCLC TherapiesMarch 22nd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: